LYPD1 (Vector Vector will be determined during the manufacturing process, either pENTR223.1 or pUC,

Length: 426 Sequence: atgtgggtcc taggcatcgc ggcaactttt tgcggattgt tcttgcttcc aggctttgcg ctgcaaatcc agtgctacca gtgtgaagaa ttccagctga acaacgactg ctcctccccc gagttcattg tgaattgcac ggtgaacgtt caagacatgt gtcagaaaga agtgatggag caaagtgccg ggatcatgta ccgcaagtcc tgtgcatcat cagcggcctg tctcatcgcc tctgccgggt accagtcctt ctgctcccca gggaaactga actcagtttg catcagctgc tgcaacaccc ctctttgtaa cgggccaagg cccaagaaaa ggggaagttc tgcctcggcc ctcaggccag ggctccgcac caccatcctg ttcctcaaat tagccctctt ctcggcacac Protein function: Believed to act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro increases receptor desensitization and decreases affinity for ACh of alpha-4:beta-2- containing nAChRs. May play a role in the intracellular trafficking of alpha-4:beta-2 and alpha-7-containing nAChRs and may inhibit their expression at the cell surface. May be involved in the control of anxiety. [The UniProt Consortium]